Quick Links
About MyBladderCancerTeam
Powered By
Below is a listing of treatments and therapies for bladder cancer. Click on one to read more information or connect with others currently using it.
Overview
Adstiladrin is approved by the U.S. Food and Drug Administration (FDA) to treat adults with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC). This includes…
Overview
Anktiva is approved by the U.S. Food and Drug Administration (FDA) along with Bacillus Calmette-Guérin (BCG) to treat adults with a type of bladder cancer called BCG-unresponsive nonmuscle invasive bladder cancer…
Overview
Balversa is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with locally advanced or metastatic urothelial carcinoma (a type of bladder cancer) with specific fibroblast growth…
Overview
Bavencio is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of locally advanced or metastatic urothelial carcinoma (a type of bladder cancer) that has not progressed with…
Overview
Keytruda is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of bladder cancer. It is prescribed to treat advanced or metastatic (spreading) urothelial cancer, the most common type…
Overview
Opdivo is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of bladder cancer, called urothelial carcinoma. It can be used after surgery to lower the risk of the cancer coming back in…
Overview
Padcev is approved by the U.S. Food and Drug Administration (FDA) for treating adults with locally advanced or metastatic urothelial cancer, the most common type of bladder cancer. It is prescribed either in…
Overview
Tepadina is approved by the U.S. Food and Drug Administration (FDA) for the treatment of superficial papillary carcinoma of the urinary bladder, a form of bladder cancer. This treatment is typically used for…
Overview
Tice BCG is approved by the U.S. Food and Drug Administration (FDA) to treat and prevent carcinoma in situ (CIS, a type of bladder cancer that stays on the bladder lining). It is also used to prevent the…
Overview
Valstar is approved by the U.S. Food and Drug Administration (FDA) to treat carcinoma in situ (CIS), a type of bladder cancer that has not spread beyond the bladder lining, in people who did not respond to…
Sign up for free!
Continue with Facebook
Sign up with your email
